Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR).

Full DD Report for RTTR

You must become a subscriber to view this report.


Recent News from (NASDAQ: RTTR)

Ritter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
Proceeds Expected to be Sufficient to Fund Company’s Liberatus Phase 3 Clinical Trial  for RP-G28 for Lactose Intolerance Through Announcement of Top-Line Data Anticipated in the Second Half of 2019 LOS ANGELES, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceutica...
Source: GlobeNewswire
Date: November, 06 2018 07:00
Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases (GI) with an init...
Source: GlobeNewswire
Date: October, 31 2018 09:21
RHT, GNW, WFT, ACB among midday movers (10/29/2018)
Gainers: Red Hat (NYSE: RHT ) +45% . Diana Containerships (NASDAQ: DCIX ) +24%  CASI Pharmaceuticals (NASDAQ: CASI ) +21% . Evogene (NYSE: EVGN ) +19%  Cooper Tire & Rubber Company (NYSE: CTB ) +18% . LM Funding America (NASDAQ: LMFA ) +17% . Stoneridge (NYSE: SRI ) +...
Source: SeekingAlpha
Date: October, 29 2018 12:47
Midday movers: TWTR, XLNX gain; ALGN, GG lose (10/25/2018)
Gainers:  TIS +20% . TBIO +17% . SNBR +17% . LJPC +17% . ATNI +16% . IMMY +15% . TWTR +15% . XLNX +15% . TRVG +14% . MORN +14% . More news on: Orchids Paper Products Company, Translate Bio, Sleep Number Corporation, Stocks on the move, , Top stock marke...
Source: SeekingAlpha
Date: October, 25 2018 12:34
Midday Gainers / Losers (09/06/2018)
Gainers: ARWR +45% . WSCI +34% . CVM +28% . ABAC +24% . CLDR +23% . SDPI +22% . NBEV +17% . SUPV +17% . AVAV +17% . IMMP +15% . More news on: Arrowhead Pharmaceuticals, WSI Industries Inc., Cel-Sci Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 06 2018 13:03
Ritter Pharmaceuticals to Present at 20th Annual HC Wainwright Global Investment Conference on September 5, 2018
LOS ANGELES, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases with an initial f...
Source: GlobeNewswire
Date: August, 28 2018 13:31
Ritter Pharmaceuticals misses by $0.15
Ritter Pharmaceuticals (NASDAQ: RTTR ): Q2 EPS of -$0.71 misses by $0.15 . More news on: Ritter Pharmaceuticals, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 14 2018 16:31

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.7610.78610.800.7641,365
2018-12-130.7690.76610.790.7614,461
2018-12-120.7310.770.77540.7320,771
2018-12-110.80850.73320.80850.73138,365
2018-12-100.840.760.87660.7344,652

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-143,03015,01520.1798Cover
2018-12-13206,3200.3165Cover
2018-12-12206792.9455Cover
2018-12-113,0144,21471.5235Short
2018-12-102,99112,84323.2890Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RTTR.


About Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR)

Logo for Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $15,792,580 - 05/18/2018
  • Issue and Outstanding: 4,950,652 - 03/23/2018

 


Recent Filings from (NASDAQ: RTTR)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 29 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 25 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018

 

 


Daily Technical Chart for (NASDAQ: RTTR)

Daily Technical Chart for (NASDAQ: RTTR)


Stay tuned for daily updates and more on (NASDAQ: RTTR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: RTTR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RTTR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of RTTR and does not buy, sell, or trade any shares of RTTR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/